Dabigatran etexilate (BIBR 1048) 是具有口服活性的 Dabigatran (一种凝血酶抑制剂)的前体。Dabigatran etexilate具有抗凝作用,可以预防心房颤动引起的静脉血栓栓塞和中风。
Dabigatran etexilate (BIBR 1048; oral; 10, 20 and 50 mg/kg for rats and 1, 2.5 and 5 mg/kg for monkeys) has dose- and time-dependent anticoagulant effects and has maximum effects between 30 and 120 min after administration, respectively[1].Dabigatran etexilate maximally and significantly prolongs partial thromboplastin time (aPTT) to 25.2, 38.4 and 78.3 s in 30 min after 10, 20 and 50 mg/kg oral doses, respectively[1].Dabigatran etexilate maximally prolongs the aPTT to 34.3 s, 44.0 s, and 63.0 s, respectively, 2h after 1, 2.5 or 5 mg/kg doses in the monkey[1].
广州优南科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
优南销售经理